Gabapentin Tablet
Product Images NDC 63187-785

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 01)

A data table titled 'Gabapentin Dosage Based on Renal Function' detailing dosage regimens according to renal function measured by creatinine clearance (mL/min). It shows total daily dose ranges and various dose regimens (mg) for multiple creatinine clearance levels, including a section for post-hemodialysis supplemental doses with corresponding notes on dosing adjustments for patients with low clearance and hemodialysis.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 02)

A formula for calculating creatinine clearance (CLCr) is shown, involving age, weight, serum creatinine, and a factor adjustment for female patients. This text panel appears to be part of clinical or pharmacokinetic information related to Gabapentin tablets 600 mg by Proficient Rx LP.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 03)

A data table titled 'TABLE 2 Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' showing risk metrics for different indications including Epilepsy, Psychiatric, Other, and Total. Columns compare the number of patients with events per 1000 in placebo and drug groups, relative risk, and risk difference.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 04)

Chemical structure of gabapentin showing a cyclohexane ring attached to an aminomethyl group and an acetic acid moiety.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 05)

A line graph depicting the mean pain score over an 8-week period for two groups: placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, labeled from baseline to week 8, and the y-axis represents mean pain score from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, showing a decreasing pain score trend for Gabapentin compared to placebo.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 06)

A line graph depicting mean pain scores over seven weeks for patients treated with placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis shows weeks from baseline to week 7, while the y-axis shows mean pain scores from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 07)

A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) at different doses. Study 1 shows 12% responders for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% responders for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg. Statistical significance is indicated by p-values (<0.01 and <0.001).*

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 08)

Chart illustrating the percentage difference plotted against daily doses of Gabapentin tablets (600 mg, 900 mg, 1200 mg, and 1800 mg). The chart compares three studies labeled as Study a, Study b, and Study c, showing varying difference percentages for each dose.*

FDA Label Image

63187-785-90 (54f184de Ba3e 4db8 Ae88 B4c06263df79 09)

Gabapentin 600 mg tablets label from Proficient Rx LP. The white, modified capsule-shaped, biconvex tablets are film coated and debossed with '1' and '2' on opposite sides of the bisect. Packaged in a quantity of 90 tablets, manufactured by InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary, with storage instructions and child safety warning included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.